Dose reduction of biologic therapy in inflammatory arthritis: A qualitative study of patients' perceptions and needs
(2018)
Journal Article
© 2018 John Wiley & Sons, Ltd. Objective: Successful biologic disease-modifying anti-rheumatic drug (bDMARD) dose reduction appears increasingly possible from clinical trials. The present study aimed to understand the patient perspective of bDMARD... Read More about Dose reduction of biologic therapy in inflammatory arthritis: A qualitative study of patients' perceptions and needs.